Ravelous is the crypto ecommerce marketplace that lets users sell their stuff online for crypto. Sellers can accept many types of payments from buyers, and withdraw your balance in the token of their choosing. Buyers who do not have the currency the sellers prefer can exchange their coins for RAVE tokens which used for payment. The RAVE tokens can also be traded for other coins, and will have a value backed by the crypto-marketplace and the RAVE treasury that will increase over time as the treasury grows in value.

Hoard is about to change the future of the video gaming industry by facilitating True Ownership of game assets on the blockchain. Today more and more people are selling virtual goods and services. With Hoard, all of this can be tokenized and made tradeable in a manner that is honest for all participants. We believe that Hoard will facilitate the global revolution in the Gaming Industry. Hoard offers a unique value-proposition to game makers and gamers alike; enabling real-world economies in games with true-ownership of virtual items, game-interoperability and new models of financing for the development of games.

Squeezer is a platform that helps software developers build apps easily without tackling the entire blockchain infrastructure. It is also a powerful tool for providing high-quality blockchain software components to large enterprise organizations. Squeezer uses world-class microservices platforms, such as AWS Lambda, Google Functions, and Azure Functions.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

TillBilly aims to bring blockchain to the mainstream retail. TillBilly is a Stellar based digital payments network with a unique point of sale hardware terminal that empowers everyday shoppers to make contactless payments, automatically get digital receipts (tax invoices) and collect loyalty reward points, without the complexity or price volatility associated with cryptocurrencies TillBilly bypasses the middlemen Merchant Services providers (card processing companies, payment gateways) who charge high processing fees per transaction (1.5% - 3.5%) and provides an ultra low fee payments network, so the shopper pays less, and the merchant gets more Protects both shoppers and merchants against any cryptocurrency price volatility. Provides a seamless way of funding wallets within app, and making payments through our proprietary tap-and-go (NFC) payment terminals. Complexities of blockchain and cryptocurrencies are hidden from shoppers and merchants.

Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.